Abstract:Stroke in China is distinguished by its high rates of morbidity, recurrence, disability, and mortality. The ultra-early administration of rtPA is essential for restoring perfusion in acute ischemic stroke, though it concurrently elevates the risk of hemorrhagic transformation. High-mobility group box 1 (HMGB1) emerges as a pivotal player in neuroinflammation after brain ischemia and ischemia–reperfusion. Released passively by necrotic cells and actively secreted, including direct secretion of HMGB1 into the extracellular space and packaging of HMGB1 into intracellular vesicles by immune cells, glial cells, platelets, and endothelial cells, HMGB1 represents a prototypical damage-associated molecular pattern (DAMP). It is intricately involved in the pathogenesis of atherosclerosis, thromboembolism, and detrimental inflammation during the early phases of ischemic stroke. Moreover, HMGB1 significantly contributes to neurovascular remodeling and functional recovery in later stages. Significantly, HMGB1 mediates hemorrhagic transformation by facilitating neuroinflammation, directly compromising the integrity of the blood–brain barrier, and enhancing MMP9 secretion through its interaction with rtPA. As a systemic inflammatory factor, HMGB1 is also implicated in post-stroke depression and an elevated risk of stroke-associated pneumonia. The role of HMGB1 extends to influencing the pathogenesis of ischemia by polarizing various subtypes of immune and glial cells. This includes mediating excitotoxicity due to excitatory amino acids, autophagy, MMP9 release, NET formation, and autocrine trophic pathways. Given its multifaceted role, HMGB1 is recognized as a crucial therapeutic target and prognostic marker for ischemic stroke and hemorrhagic transformation. In this review, we summarize the structure and redox properties, secretion and pathways, regulation of immune cell activity, the role of pathophysiological mechanisms in stroke, and hemorrhage transformation for HMGB1, which will pave the way for developing new neuroprotective drugs, reduction of post-stroke neuroinflammation, and expansion of thrombolysis time window.

High-Mobility Group Box 1 Promotes Metalloproteinase-9 Upregulation Through Toll-Like Receptor 4 after Cerebral Ischemia

The Role of High Mobility Group Box 1 in Ischemic Stroke

Early Release of HMGB-1 from Neurons after the Onset of Brain Ischemia

Effects of HMGB1 on MMP-9 Expression in Rat Cardiac Fibroblasts

The Roles of High Mobility Group Box 1 in Cerebral Ischemic Injury

Activation of the High-Mobility Group Box 1 Protein-Receptor for Advanced Glycation End-Products Signaling Pathway in Rats During Neurogenesis after Intracerebral Hemorrhage

HMGB1 promoted P-glycoprotein at the blood-brain barrier in MCAO rats via TLR4/NF-κB signaling pathway

HMGB1 May Act Via RAGE to Promote Angiogenesis in the Later Phase after Intracerebral Hemorrhage

HMGB1 promotes neurovascular remodeling via Rage in the late phase of subarachnoid hemorrhage

HMGB1: A New Target for Ischemic Stroke and Hemorrhagic Transformation

High-mobility Group Box1 Protein Promotes Neuroinflammation after Intracerebral Hemorrhage in Rats

Matrix Metalloproteinase-9 Expression is Enhanced by Ischemia and Tissue Plasminogen Activator and Induces Hemorrhage, Disability and Mortality in Experimental Stroke

Blockade of High Mobility Group Box-1 Signaling Via the Receptor for Advanced Glycation End-Products Ameliorates Inflammatory Damage after Acute Intracerebral Hemorrhage

High mobility group box-1 protein promotes astrocytic CCL5 production through the MAPK/NF-κB pathway following spinal cord injury

HMGB1-Driven Inflammation and Intimal Hyperplasia after Arterial Injury Involves Cell-Specific Actions Mediated by TLR4

High Mobility Group Box 1 Activates Toll Like Receptor 4 Signaling in Hepatic Stellate Cells

Hypoxia Response Element-Regulated MMP-9 Promotes Neurological Recovery Via Glial Scar Degradation and Angiogenesis in Delayed Stroke

Mmp-9, a Potential Target for Cerebral Ischemic Treatment.

Analysis of the expression of nine secreted matrix metalloproteinases and their endogenous inhibitors in the brain of mice subjected to ischaemic stroke

Matrix Metalloproteinase Expression Is Related to Hemorrhagic Transformation After Cardioembolic Stroke

HMGB1/TLR4 axis promotes pyroptosis after ICH by activating the NLRP3 inflammasome